Background
The causal relationships between testosterone, estradiol, estrogen sulfotransferase, and idiopathic pulmonary fibrosis (IPF) are not well understood. This study employs a bidirectional two-sample Mendelian Randomization (MR) approach to explore these associations.
Methods
We extracted significant genetic loci associated with testosterone, estradiol, and estrogen sulfotransferase from GWAS summary data as instrumental variables, with IPF as the outcome variable for a two-sample Mendelian randomization analysis. Instrumental variables and outcome variables were then swapped for a bidirectional two-sample Mendelian randomization analysis. The inverse variance weighted (IVW), MR-Egger, and weighted median methods were used to evaluate causal relationships. Cochran's Q test, MR-Egger regression, MR-PRESSO global test, and leave-one-out method were used for sensitivity analyses.
Results
Genetically predicted increases in serum testosterone levels by one standard deviation were associated with a 58.7% decrease in the risk of developing IPF (OR = 0.413, PIVW=0.029, 95% CI = 0.187 ~ 0.912), while an increase in serum estrogen sulfotransferase by one standard deviation was associated with a 32.4% increase in risk (OR = 1.324, PIVW=0.006, 95% CI = 1.083 ~ 1.618). No causal relationship was found between estradiol (OR = 1.094, PIVW=0.735, 95% CI = 0.650 ~ 1.841) and the risk of IPF. Reverse MR analysis did not reveal any causal relationship between IPF and testosterone (OR = 1.001, PIVW=0.51, 95% CI = 0.998 ~ 1.004), estradiol (OR = 1.001, PIVW=0.958, 95% CI = 0.982 ~ 1.019), or estrogen sulfotransferase (OR = 0.975, PIVW=0.251, 95% CI = 0.933 ~ 1.018).
Conclusions
Increased serum levels of testosterone are associated with a reduced risk of IPF, while increased levels of serum estrogen sulfotransferase are associated with an increased risk. No causal relationship was found between estradiol and the development of IPF. No causal relationship was identified between IPF and testosterone, estradiol, or estrogen sulfotransferase.